1766 related articles for article (PubMed ID: 18171610)
21. Antiprothrombin antibody: why do we need more assays?
Atsumi T; Koike T
Lupus; 2010 Apr; 19(4):436-9. PubMed ID: 20353984
[TBL] [Abstract][Full Text] [Related]
22. Antiphospholipid antibodies, antiphospholipid syndrome and infections.
Sène D; Piette JC; Cacoub P
Autoimmun Rev; 2008 Feb; 7(4):272-7. PubMed ID: 18295729
[TBL] [Abstract][Full Text] [Related]
23. Role of anti-domain 1-β2 glycoprotein I antibodies in the diagnosis and risk stratification of antiphospholipid syndrome.
De Craemer AS; Musial J; Devreese KM
J Thromb Haemost; 2016 Sep; 14(9):1779-87. PubMed ID: 27314634
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism.
de Laat B; Mertens K; de Groot PG
Nat Clin Pract Rheumatol; 2008 Apr; 4(4):192-9. PubMed ID: 18285765
[TBL] [Abstract][Full Text] [Related]
25. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
Miesbach W; Matthias T; Scharrer I
Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
[TBL] [Abstract][Full Text] [Related]
26. Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome.
Mondejar R; González-Rodríguez C; Toyos-Sáenz de Miera FJ; Melguizo-Madrid E; Zohoury N; Mahler M; Romero Losquiño I; Fabiani F
Clin Chim Acta; 2014 Apr; 431():174-8. PubMed ID: 24522162
[TBL] [Abstract][Full Text] [Related]
27. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
28. Does the anti-prothrombin antibodies measurement provide additional information in patients with thrombosis?
Bardin N; Alessi MC; Dignat-George F; Vague IJ; Sampol J; Harlé JR; Sanmarco M
Immunobiology; 2007; 212(7):557-65. PubMed ID: 17678713
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
Cabral AR; Cabiedes J; Alarcón-Segovia D
Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
[TBL] [Abstract][Full Text] [Related]
30. European attempts for the standardisation of the antiphospholipid antibodies.
Tincani A; Filippini M; Scarsi M; Galli M; Meroni PL
Lupus; 2009 Sep; 18(10):913-9. PubMed ID: 19671792
[TBL] [Abstract][Full Text] [Related]
31. Clinical consequences of antiphospholipid antibodies.
Derksen RH; de Groot PG
Neth J Med; 2004 Sep; 62(8):273-8. PubMed ID: 15588067
[TBL] [Abstract][Full Text] [Related]
32. [Antiphospholipid syndrome].
Steffen M
Immun Infekt; 1992 Aug; 20(4):122-4. PubMed ID: 1398731
[TBL] [Abstract][Full Text] [Related]
33. Antiphospholipid syndrome: long-time research on pathogenic mechanisms has finally lead to new therapeutic strategies.
Cervera R; Espinosa G
Expert Opin Ther Targets; 2010 Dec; 14(12):1279-82. PubMed ID: 21058919
[TBL] [Abstract][Full Text] [Related]
34. Interaction of giant phospholipid vesicles containing cardiolipin and cholesterol with beta2-glycoprotein-I and anti-beta2-glycoprotein-I antibodies.
Ambrozic A; Cucnik S; Tomsic N; Urbanija J; Lokar M; Babnik B; Rozman B; Iglic A; Kralj-Iglic V
Autoimmun Rev; 2006 Nov; 6(1):10-5. PubMed ID: 17110310
[TBL] [Abstract][Full Text] [Related]
35. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome.
Galli M
Semin Thromb Hemost; 2008 Jun; 34(4):329-34. PubMed ID: 18814065
[TBL] [Abstract][Full Text] [Related]
36. [Antiphospholipid syndrome diagnosis: an update].
Visseaux B; Masliah-Planchon J; Fischer AM; Darnige L
Ann Biol Clin (Paris); 2011; 69(4):411-8. PubMed ID: 21896405
[TBL] [Abstract][Full Text] [Related]
37. Women's Issues in Antiphospholipid Syndrome.
Papadakis E; Banti A; Kioumi A
Isr Med Assoc J; 2016 Sep; 18(9):524-529. PubMed ID: 28471597
[TBL] [Abstract][Full Text] [Related]
38. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Danowski A; Kickler TS; Petri M
J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
[TBL] [Abstract][Full Text] [Related]
39. Antibodies to age-β2 glycoprotein I in patients with anti-phospholipid antibody syndrome.
Sorice M; Buttari B; Capozzi A; Profumo E; Facchiano F; Truglia S; Recalchi S; Alessandri C; Conti F; Misasi R; Valesini G; Riganò R
Clin Exp Immunol; 2016 May; 184(2):174-82. PubMed ID: 26702877
[TBL] [Abstract][Full Text] [Related]
40. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
Delgado Alves J; Kumar S; Isenberg DA
Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
